Total Synthesis Time (total + synthesis_time)

Distribution by Scientific Domains


Selected Abstracts


Radiosynthesis of [11C]ximelagatran via palladium catalyzed [11C]cyanation

JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, Issue 1 2008
Anu J. Airaksinen
Abstract N -hydroxyamidines (amidoximes) may be used in prodrug technology in improving oral bioavailability of drugs containing amidino functional groups. In the body, amidoximes are reduced quickly to amidines by enzymes that are present in several organs. Ximelagatran is a benzamidoxime and ethyl ester prodrug of melagatran, which is a thrombin inhibitor. Our aim was to develop a fast and efficient labeling route for the synthesis of [11C]ximelagatran ([11C]3) with a label in a metabolically stable position. [11C]3 was synthesized via a two-step synthesis sequence, starting from palladium catalyzed [11C]cyanation of its corresponding bromide precursor (2-[2-(4-bromo-benzylcarbamoyl)-azetidin-1-yl]-1-cyclohexyl-2-oxo-ethyl amino-acetic acid ethyl ester) (1), followed by a reaction with hydroxylamine. [11C]3 was synthesized with 27±17% total overall decay corrected yield (specific radioactivity of 2360±165,Ci/mmol at EOS), with a total synthesis time of 45,min. A fast and efficient labeling route for the synthesis of [11C]3 was developed. Copyright © 2008 John Wiley & Sons, Ltd. [source]


Synthesis of 2-[(2-chloro-2,-[18F]fluoroethyl)amino]-2H-1,3,2-oxazaphosphorinane-2-oxide (18F-fluorocyclophosphamide), a potential tracer for breast tumor prognostic imaging with PET

JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, Issue 9 2005
Goran Lacan
Abstract A fluorine-18 labeled analog of the widely used chemotherapeutic agent cyclophosphamide was synthesized as a tracer for prognostic imaging with positron emission tomography. 2-[(2-Chloro-2,-[18F]fluoroethyl)amino]-2H-1,3,2-oxazaphosphorinane-2-oxide (18F-fluorocyclophosphamide), was prepared by direct halogen exchange reaction from the parent cyclophosphamide. In small-scale syntheses, radiochemical yields of up to 4.9% and specific activities of 960 Ci/mmol were achieved in a total synthesis time of 60,75 min. The [18F]-labeled cyclophosphamide analog with radioactive purity >99% and chemical purity >96% was suitable for in vivo (microPET imaging) and ex vivo studies of a murine model of human breast tumors. Copyright © 2005 John Wiley & Sons, Ltd. [source]


Synthesis and preliminary in vivo evaluation of 4-[18F]fluoro- N -{2-[4-(6-trifluoromethylpyridin-2-yl)piperazin-1-yl]ethyl}benzamide, a potential PET radioligand for the 5-HT1A receptor

JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, Issue 9 2004
M. Vandecapelle
Abstract 4-Fluoro- N -{2-[4-(6-trifluoromethylpyridin-2-yl)piperazin-1-yl]ethyl}benzamide is a full 5-HT1A agonist with high affinity (pKi=9.3), selectivity and a c log P of 3.045. The corresponding PET radioligand 4-[18F]fluoro- N -{2-[4-(6-trifluoromethylpyridin-2-yl)piperazin-1-yl]ethyl}benzamide was synthesized by nucleophilic aromatic substitution on the nitro precursor. The fluorinating agent K[18F]F/Kryptofix 2.2.2 was both dried (9 min, 700 W) and incorporated in the precursor (5 min, 700 W) using a commercially available microwave oven. In a total synthesis time of 60 min, an overall radiochemical yield of 18% (SD=5, n=7, EOS) was obtained. Radiochemical purity was always higher than 99% and specific activity always higher than 81.4 GBq/µmol (2.2 Ci/µmol). Initial brain uptake in mice was 2.19% ID (5.47% ID/g, 2 min) but decreased rapidly (0.17% ID, 0.45% ID/g (60 min)). During the first 20 min p.i., radioactivity concentration of the brain was significantly higher than that of blood demonstrating good brain entry of the tracer. Copyright © 2004 John Wiley & Sons, Ltd. [source]


Resin comparison and fast automated stepwise conventional synthesis of human SDF-1,

JOURNAL OF PEPTIDE SCIENCE, Issue 12 2008
Hirendra Patel
Abstract Human SDF-1, contains 68 amino acids and is a member of the chemokine family of peptides. This long peptide was synthesized stepwise using classical conditions in 101 h. The reaction times were then reduced to deprotection times of 2 × 2 min and coupling times of 2 × 2.5 min, resulting in a total synthesis time of 22 h. The effect of different resins, resin substitutions and deprotection reagents on the crude peptide purities was compared. A small portion of crude peptide was purified using an RP-HPLC column and the mass of the final product was confirmed with MALDI-TOF mass spectrometry. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd. [source]